Oxford Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
+5,762
| New | +$281K | 0.1% | 319 |
|
|
2024
Q2 | – | Sell |
-9,313
| Closed | -$271K | – | 390 |
|
|
2024
Q1 | $271K | Buy |
+9,313
| New | +$271K | 0.28% | 133 |
|
|
2018
Q4 | – | Sell |
-42,023
| Closed | -$2.02M | – | 2027 |
|
|
2018
Q3 | $2.02M | Sell |
42,023
-35,608
| -46% | -$1.71M | 0.04% | 657 |
|
|
2018
Q2 | $2.57M | Buy |
77,631
+65,466
| +538% | +$2.16M | 0.05% | 511 |
|
|
2018
Q1 | $329K | Sell |
12,165
-20
| -0.2% | -$541 | 0.01% | 1380 |
|
|
2017
Q4 | $206K | Sell |
12,185
-83,686
| -87% | -$1.41M | ﹤0.01% | 1449 |
|
|
2017
Q3 | $1.9M | Buy |
+95,871
| New | +$1.9M | 0.04% | 644 |
|
|
2017
Q1 | – | Sell |
-136,592
| Closed | -$1.49M | – | 1458 |
|
|
2016
Q4 | $1.49M | Buy |
+136,592
| New | +$1.49M | 0.05% | 392 |
|